ArcherDx Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit A federal jury ruled that various Qiagen sample prep products infringe a pair of US patents underlying ArcherDx's anchored multiplex PCR technology. M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags. Invitae Q3 Revenues Increase 22 Percent The firm generated $68.7 million in revenues compared to $56.5 million in Q3 2019 and exceeded the consensus Wall Street estimate. Natera Sues Genosity for Patent Infringement Relating to ArcherDx Products Natera claims that several Genosity products infringe its US Patent No. 10,732,220, titled "Methods for Simultaneous Amplification of Target Loci." Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit Last month, the court also ordered two separate patent lawsuits filed by Natera against ArcherDx this year to be consolidated into one. Oct 5, 2020 Invitae Completes Acquisition of ArcherDx Aug 7, 2020 Natera Files Additional Patent Infringement Lawsuit Against ArcherDx Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 22, 2020 Invitae, ArcherDx Ink $1.4B Merger to Advance Precision Oncology Offerings Jun 18, 2020 ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring Jun 7, 2020 ArcherDx Targeting $100M in IPO May 26, 2020 AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials May 14, 2020 ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development Apr 21, 2020 ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers Apr 15, 2020 Natera Expands IP Lawsuit Against ArcherDx With Three New Patents Mar 25, 2020 Japanese Regulators Approve Merck KGaA MET Inhibitor With ArcherDx CDx Jan 27, 2020 Natera Sues ArcherDx for Infringement of New Target Amplification Patent Jan 10, 2020 ArcherDx, Illumina Agree to Comarket Future IVDs Dec 17, 2019 ArcherDx Closes $55M Series C Financing Dec 3, 2019 Illumina, ArcherDx Expand Partnership on NGS IVD Tests Jul 8, 2019 Ayala, ArcherDx Partner to Advance CDx for Notch Inhibitors May 24, 2019 Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays Premium May 15, 2019 ArcherDx Raises $60M in Series B Financing Round Apr 2, 2019 Combined Analysis of DNA, RNA Gaining Popularity in Pediatric Cancer Research Feb 12, 2019 ArcherDx to Comarket Genosity Consulting, Lab Software Services Load More Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.